Understanding neuropathic pain in patients with Type II diabetes
The Effect of Neuropathic Pain on Self-Care Ability and Quality of Life in Type II Diabetic Patients
Bilecik Seyh Edebali Universitesi · NCT06798181
This study looks at how neuropathic pain affects the daily lives of people with Type II diabetes who visit a specific outpatient clinic.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 128 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Bilecik Seyh Edebali Universitesi (other) |
| Locations | 1 site (Bilecik) |
| Trial ID | NCT06798181 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the impact of neuropathic pain on the quality of life in patients diagnosed with Type II diabetes. Researchers will collect data through face-to-face interviews using validated scales to evaluate symptoms, self-care efficacy, and overall quality of life. The study will focus on patients attending the Internal Medicine Outpatient Clinic at Bilecik Seyh Edebali University. The goal is to gather comprehensive data on the prevalence and characteristics of diabetic neuropathy in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with Type II diabetes and can communicate effectively in Turkish.
Not a fit: Patients diagnosed with Type I diabetes will not benefit from this study as they do not meet the inclusion criteria.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for neuropathic pain in Type II diabetic patients, enhancing their quality of life.
How similar studies have performed: While there have been studies on diabetic neuropathy, this specific observational approach focusing on quality of life in Type II diabetes patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years and older, * Diagnosed with type II diabetes, * Reading and writing, * No physical or psychological communication barriers, * Can read and speak Turkish, * Volunteers Exclusion Criteria: * Diagnosed with type I diabetes
Where this trial is running
Bilecik
- Bilecik Seyh Edeabli University — Bilecik, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Burcu Bayrak Kahraman, PhD
- Email: burcu.bayrak@bilecik.edu.tr
- Phone: +905057542411
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neuropathic Pain, Quality of Life, Diabetic Neuropathies